Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Psychosom Med ; 84(2): 224-230, 2022.
Article in English | MEDLINE | ID: mdl-34840289

ABSTRACT

OBJECTIVE: Anger may cause adverse cardiovascular responses, but the effects of anger management on clinical cardiovascular outcomes are insufficiently understood. We sought to assess the influence of anger management through a cognitive behavioral intervention on endothelial function in patients with a recent myocardial infarction (MI). METHODS: Patients with ST-elevation MI and a low anger control score were enrolled during hospitalization in a randomized, parallel, controlled clinical trial. Intervention was anger management with cognitive behavioral techniques implemented by a psychologist in two individual monthly sessions. The primary end point was the between-group difference in the variation of flow-mediated dilation (FMD) in the brachial artery from baseline to the 3-month follow-up. The second end point comprised major cardiovascular events at 24-month follow-up. RESULTS: A total of 43 patients (age = 56 [9] years; 23.3% women) were randomized to the intervention group and 47 patients (age = 58 [10] years; 19.1% women) to the control group. Baseline clinical characteristics were not statistically different between groups. Both groups showed a significant improvement in anger control from baseline to end point; however, the difference in intergroup variation was not statistically significant. The difference in FMD variation from baseline to the 3-month follow-up was significantly higher in the intervention group. The partial η2 was 0.057 (p = .024), indicating a medium effect size. There was no difference between groups regarding major cardiovascular events. CONCLUSIONS: Anger management by cognitive behavioral techniques may improve endothelial function in post-MI patients with low anger control, but it remains unclear via which mechanism these effects occurred. Further studies with larger numbers of patients, assessments of changes in anger, improved comparability of preintervention FMD, and longer follow-up are warranted.Trial Registration:ClinicalTrials.gov identifier: NCT02868216.


Subject(s)
Anger Management Therapy , Myocardial Infarction , ST Elevation Myocardial Infarction , Cognition , Female , Humans , Male , Middle Aged , Myocardial Infarction/therapy , Treatment Outcome
2.
J Card Fail ; 15(10): 828-34, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19944358

ABSTRACT

BACKGROUND: The cytokine hypothesis suggests that there is an association between chronic heart failure (CHF) and inflammation. Methotrexate could improve CHF patients' clinical status, especially those with ischemic etiology. METHODS AND RESULTS: METIS is a randomized, double-blinded trial studying 50 patients with ischemic CHF given methotrexate (7.5mg) or placebo, plus folic acid (5mg), for 12 weeks. The primary end point was the difference in 6-minute walk test (6MWT) distance before and after treatment. We also evaluated functional class (NYHA), Short-Form 36 protocol quality of life, C-reactive protein (CRP), incidence of adverse effects, and the combined incidence of death, myocardial infarction, stroke, hospitalization, and need for myocardial revascularization. There was no significant difference between groups in distance covered in the 6MWT: the methotrexate group improved by 24.5+/-39.5m, the placebo group by 21.3+/-43.7m (P=.80). The NYHA scores improved in 66.7% of the methotrexate group patients and in 50.0% of the placebo group (P=.2). SF-36 scores indicated improved mental health in the placebo group. There were no significant differences in CRP levels, the combined outcome, or adverse events. CONCLUSIONS: These results show that the methotrexate group tended toward improved NYHA scores and that there were no significant changes in 6MWT results or secondary assessments.


Subject(s)
Heart Failure/drug therapy , Methotrexate/pharmacology , Methotrexate/therapeutic use , Myocardial Ischemia/drug therapy , Physical Endurance/drug effects , Aged , Double-Blind Method , Exercise Test/methods , Female , Follow-Up Studies , Heart Failure/complications , Heart Failure/physiopathology , Humans , Male , Middle Aged , Myocardial Ischemia/complications , Myocardial Ischemia/physiopathology , Physical Endurance/physiology , Recovery of Function/drug effects , Recovery of Function/physiology , Treatment Outcome
3.
Arq Bras Cardiol ; 111(3): 410-416, 2018 Sep.
Article in English, Portuguese | MEDLINE | ID: mdl-30281687

ABSTRACT

BACKGROUND: Anger control was significantly lower in patients with coronary artery disease (CAD), regardless of traditionally known risk factors, occurrence of prior events or other anger aspects in a previous study of our research group. OBJECTIVE: To assess the association between anger and CAD, its clinical course and predictors of low anger control in women submitted to coronary angiography. METHODS: This is a cohort prospective study. Anger was assessed by use of Spielberger's State-Trait Anger Expression Inventory (STAXI). Women were consecutively scheduled to undergo coronary angiography, considering CAD definition as ≥ 50% stenosis of one epicardial coronary artery. RESULTS: During the study, 255 women were included, being divided into two groups according to their anger control average (26.99). Those with anger control below average were younger and had a family history of CAD. Patients were followed up for 48 months to verify the occurrence of major cardiovascular events. CONCLUSION: Women with CAD undergoing coronary angiography had lower anger control, which was associated with age and CAD family history. On clinical follow-up, event-free survival did not significantly differ between patients with anger control above or below average.


Subject(s)
Anger , Coronary Artery Disease/psychology , Aged , Coronary Angiography/methods , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/mortality , Diabetes Mellitus/psychology , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Logistic Models , Middle Aged , Personality Inventory , Prospective Studies , Risk Factors , Statistics, Nonparametric
4.
Arq Bras Cardiol ; 111(4): 587-593, 2018 Oct.
Article in English, Portuguese | MEDLINE | ID: mdl-30281695

ABSTRACT

BACKGROUND: In patients with acute ST-segment elevation myocardial infarction (STEMI), the time elapsed from symptom onset to receiving medical care is one of the main mortality predictors. OBJECTIVE: To identify independent predictors of late presentation in patients STEMI representative of daily clinical practice. METHODS: All patients admitted with a diagnosis of STEMI in a reference center between December 2009 and November 2014 were evaluated and prospectively followed during hospitalization and for 30 days after discharge. Late presentation was defined as a time interval > 6 hours from chest pain onset until hospital arrival. Multiple logistic regression analysis was used to identify independent predictors of late presentation. Values of p < 0.05 were considered statistically significant. RESULTS: A total of 1,297 patients were included, with a mean age of 60.7 ± 11.6 years, of which 71% were males, 85% Caucasians, 72% had a mean income lower than five minimum wages and 66% had systemic arterial hypertension. The median time of clinical presentation was 3.00 [1.40-5.48] hours, and approximately one-quarter of the patients had a late presentation, with their mortality being significantly higher. The independent predictors of late presentation were Black ethnicity, low income and diabetes mellitus, and a history of previous heart disease was a protective factor. CONCLUSION: Black ethnicity, low income and diabetes mellitus are independent predictors of late presentation in STEMI. The identification of subgroups of patients prone to late presentation may help to stimulate prevention policies for these high-risk individuals.


Subject(s)
ST Elevation Myocardial Infarction/physiopathology , Aged , Brazil , Diabetes Mellitus/physiopathology , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Prospective Studies , Risk Factors , ST Elevation Myocardial Infarction/mortality , Socioeconomic Factors , Statistics, Nonparametric , Time Factors , Time-to-Treatment
5.
J Cardiovasc Pharmacol Ther ; 22(6): 538-545, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28325070

ABSTRACT

PURPOSE: Methotrexate is an anti-inflammatory drug that has been shown to have anti-ischemic effects. Our aim was to evaluate if methotrexate could reduce infarct size in patients with ST-segment elevation myocardial infarction (STEMI). METHODS: We randomly assigned patients with STEMI to receive either methotrexate or placebo. Primary outcome was infarct size determined by calculating the area under the curve (AUC) for creatine kinase (CK) release. Secondary outcomes were AUC of CK MB (CK-MB) and AUC of troponin I; peak CK, peak CK-MB, and troponin I; B-type natriuretic peptide (BNP) level, high-sensitivity C-reactive protein (hsCRP) result, and erythrocyte sedimentation rate (ESR); left ventricular ejection fraction (LVEF); thrombolysis in myocardial infarction (TIMI) frame count; Killip score; mortality and reinfarction incidence; and incidence of adverse reactions. RESULTS: We included 84 patients. Median AUC of CK was 78 861.0 in the methotrexate group and 68 088.0 in the placebo group ( P = .10). Patients given methotrexate and placebo exhibited, respectively, median AUC for CK-MB of 9803.4 and 8037.0 ( P = .42); median AUC for troponin of 3691.1 and 2132.6 ( P = .09); peak CK of 2806.0 and 2147.0 ( P = .05); peak CK-MB of 516.0 and 462.3 ( P = .25); and peak troponin of 121.0 and 85.1 ( P = .06). At 3 months, LVEF was lower in patients who received methotrexate (49.0% ± 14.1%) than in patients given placebo (56.4% ± 10.0%; P = .01). There were no differences in hsCRP, ESR, BNP, Killip scores, TIMI frame count, reinfarction, and mortality rates. There was a higher median serum glutamic-pyruvic transaminase levels in the methotrexate group. CONCLUSION: Methotrexate did not reduce infarction size and worsened LVEF at 3 months ( Clinicaltrials.gov identifier NCT01741558).


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Methotrexate/administration & dosage , ST Elevation Myocardial Infarction/diagnosis , ST Elevation Myocardial Infarction/drug therapy , Aged , Double-Blind Method , Female , Humans , Infusions, Intravenous , Injections, Intravenous , Male , Middle Aged , Prospective Studies , ST Elevation Myocardial Infarction/blood
6.
Arch Med Sci Atheroscler Dis ; 1(1): e44-e48, 2016.
Article in English | MEDLINE | ID: mdl-28905018

ABSTRACT

INTRODUCTION: Regarding the inflammatory mechanisms involved in ischemic heart disease, currently the leukocyte count is the subject of studies related to its association with the prognosis and mortality of ST segment elevation myocardial infarction (STEMI). Our aim is correlate the leukocyte count rise with the size of STEMI, evaluated with the area under the curve (AUC) and the peak of necrosis markers release. MATERIAL AND METHODS: This study is a sub-analysis of the TETHYS trial, a clinical trial that evaluated the effects of methotrexate in STEMI. We evaluated the correlation between quantitative variables with Pearson's correlation, and the variables that did not follow a normal distribution were subjected to logarithmic transformation to base 10. The value of p < 0.05 indicated statistical significance. RESULTS: Males accounted for 73% of the participants, who had an average age of 59 years. A total of 58% were hypertensive and 53% smokers. The leukocyte count at hospital admission was significantly correlated with the AUC creatine kinase (CK) (r = 0.256, p = 0.021), troponin AUC (r = 0.247, p = 0.026), peak CK (r = 0.270, p = 0.015) and troponin peak (r = 0.233, p = 0.037). The leukocyte count at 72 h was significantly correlated with CK AUC (r = 0.238, p = 0.032), AUC of MB portion of CK (r = 0.240, p = 0.031) and peak CK (r = 0.224, p = 0.045). CONCLUSIONS: White blood cell count correlates with STEMI size assessed by serial cardiac biomarker levels.

7.
Am J Cardiovasc Drugs ; 15(1): 1-11, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25369900

ABSTRACT

Coronary artery disease (CAD) and acute myocardial infarction (AMI) are inflammatory pathologies, involving interleukins (ILs), such as IL-1ß, IL-6 and tumor necrosis factor (TNF)-α, and acute phase proteins production, such as for C reactive protein (CRP). The process begins with retention of low-density lipoprotein (LDL) and its oxidation inside the intima, with the formation of the "foam cells." Toll-like receptors and inflamassomes participate in atherosclerosis formation, as well as in the activation of the complement system. In addition to innate immunity, adaptive immunity is also associated with atherosclerosis through antigen-presenting cells, T and B lymphocytes. AMI also increases the expression of some ILs and promotes macrophage and lymphocyte accumulation. Reperfusion increases the expression of anti-inflammatory ILs (such as IL-10) and generates oxygen free radicals. Although CAD and AMI are inflammatory disorders, the only drugs with anti-inflammatory effect so far widely used in ischemic heart disease are aspirin and statins. Some immunomodulatory or immunosuppressive promising therapies, such as cyclosporine and colchicine, may have benefits in CAD. Methotrexate also has potential cardioprotective anti-inflammatory effects, through increased adenosine levels. The TETHYS trial (The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS trial) will evaluate low-dose methotrexate in ST elevation AMI. The CIRT (Cardiovascular Inflammation Reduction Trial), in turn, will evaluate low-dose methotrexate in patients with a high prevalence of subclinical vascular inflammation. The CANTOS (The Canakinumab Antiinflammatory Thrombosis Outcomes Study) will evaluate canakinumab in patients with CAD and persistently elevated CRP. The blockage of other potential targets, such as the IL-6 receptor, CC2 chemokine receptor and CD20, could bring benefits in CAD.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cardiovascular Agents/therapeutic use , Coronary Artery Disease/drug therapy , Coronary Thrombosis/prevention & control , Evidence-Based Medicine , Models, Immunological , Vasculitis/prevention & control , Acute Coronary Syndrome/drug therapy , Acute Coronary Syndrome/immunology , Acute Coronary Syndrome/metabolism , Acute Coronary Syndrome/physiopathology , Adaptive Immunity/drug effects , Animals , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Atherosclerosis/drug therapy , Atherosclerosis/immunology , Atherosclerosis/metabolism , Atherosclerosis/physiopathology , Cardiovascular Agents/adverse effects , Coronary Artery Disease/immunology , Coronary Artery Disease/metabolism , Coronary Artery Disease/physiopathology , Coronary Thrombosis/etiology , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Endothelium, Vascular/metabolism , Humans , Immunity, Innate/drug effects , Myocardial Infarction/etiology , Myocardial Infarction/prevention & control , Myocardial Reperfusion Injury/etiology , Myocardial Reperfusion Injury/prevention & control , Vasculitis/etiology
8.
Arq Bras Cardiol ; 105(6): 573-9, 2015 Dec.
Article in English, Portuguese | MEDLINE | ID: mdl-26761368

ABSTRACT

BACKGROUND: Due to the importance of coronary artery disease (CAD), continuous investigation of the risk factors (RFs) is needed. OBJECTIVE: To evaluate the prevalence of RFs for CAD in cities in Rio Grande do Sul State, and compare it with that reported in a similar study conducted in the same cities in 2002. METHODS: Cross-sectional study on 1,056 healthy adults, investigating the prevalence and absolute and relative frequencies of the following RFs for CAD: obesity, systemic arterial hypertension (SAH), dyslipidemias, smoking, sedentary lifestyle, diabetes mellitus, and family history, as well as age and sex. Data was collected in 19 cities, host of the Offices of the Regional Coordinators of Health, as in the 2002 study. RESULTS: Twenty-six percent of the sample consisted of older adults and 57% were women. The prevalence of sedentary lifestyle was 44%, history family 50%, smoking 23%, overweight/obesity 68%, dyslipidemia (high cholesterol levels) 43%, SAH 40%, and diabetes 11%. When compared to the 2002 study, the prevalence of active smoking and sedentary behavior decreased, whereas the prevalence of hypertension, dyslipidemia and obesity increased. Obesity is the most prevalent RF in women, and SAH the most prevalent in men. CONCLUSIONS: The prevalence of RFs for CAD in Rio Grande do Sul State remains high. Hypertension, obesity and dyslipidemia are still prevalent and require major prevention programs. Smoking and physical inactivity have decreased in the state, suggesting the efficacy of related campaigns.


Subject(s)
Coronary Artery Disease/etiology , Diabetes Mellitus/epidemiology , Dyslipidemias/epidemiology , Hypertension/epidemiology , Obesity/epidemiology , Smoking/epidemiology , Adult , Age Factors , Aged , Brazil/epidemiology , Coronary Artery Disease/epidemiology , Cross-Sectional Studies , Diabetes Complications , Dyslipidemias/complications , Female , Humans , Hypertension/complications , Male , Middle Aged , Obesity/complications , Prevalence , Risk Factors , Sedentary Behavior , Sex Factors , Smoking/adverse effects
9.
Arq Bras Cardiol ; 103(4): 323-30, 2014 Oct.
Article in English, Portuguese | MEDLINE | ID: mdl-25352506

ABSTRACT

BACKGROUND: Diabetes mellitus and admission blood glucose are important risk factors for mortality in ST segment elevation myocardial infarction patients, but their relative and individual role remains on debate. OBJECTIVE: To analyze the influence of diabetes mellitus and admission blood glucose on the mortality of ST segment elevation myocardial infarction patients submitted to primary coronary percutaneous intervention. METHODS: Prospective cohort study including every ST segment elevation myocardial infarction patient submitted to primary coronary percutaneous intervention in a tertiary cardiology center from December 2010 to May 2012. We collected clinical, angiographic and laboratory data during hospital stay, and performed a clinical follow-up 30 days after the ST segment elevation myocardial infarction. We adjusted the multivariate analysis of the studied risk factors using the variables from the GRACE score. RESULTS: Among the 740 patients included, reported diabetes mellitus prevalence was 18%. On the univariate analysis, both diabetes mellitus and admission blood glucose were predictors of death in 30 days. However, after adjusting for potential confounders in the multivariate analysis, the diabetes mellitus relative risk was no longer significant (relative risk: 2.41, 95% confidence interval: 0.76 - 7.59; p-value: 0.13), whereas admission blood glucose remained and independent predictor of death in 30 days (relative risk: 1.05, 95% confidence interval: 1.02 - 1.09; p-value ≤ 0.01). CONCLUSION: In ST segment elevation myocardial infarction patients submitted to primary coronary percutaneous intervention, the admission blood glucose was a more accurate and robust independent predictor of death than the previous diagnosis of diabetes. This reinforces the important role of inflammation on the outcomes of this group of patients.


Subject(s)
Blood Glucose/analysis , Diabetes Complications/mortality , Myocardial Infarction/mortality , Myocardial Infarction/surgery , Percutaneous Coronary Intervention/mortality , Aged , Biomarkers/blood , Female , Hospital Mortality , Hospitalization , Humans , Male , Middle Aged , Multivariate Analysis , Myocardial Infarction/blood , Percutaneous Coronary Intervention/adverse effects , Prospective Studies , Risk Assessment , Risk Factors , Treatment Outcome
10.
Arq Bras Cardiol ; 101(6): 502-10, 2013 Dec.
Article in English, Portuguese | MEDLINE | ID: mdl-24162472

ABSTRACT

BACKGROUND: Percutaneous Coronary Intervention (PCI) is the most common strategy for the treatment of Acute ST segment elevation Myocardia Infarction (STEMI), and thromboaspiration has been increasingly utilized for removal of occlusive thrombi. OBJECTIVES: To analyze the influence of histopathological features of coronary thrombi in clinical outcomes of patients with STEMI, and the association of these variables with clinical, angiographic, and laboratory features and medications used in hospitalization. METHODS: Prospective cohort study. All patients were monitored during hospitalization and thirty days after the event. Aspirated thrombi were preserved in formalin and subsequently stained with hematoxylin-eosin and embedded in paraffin. Thrombi were classified as recent and old. The primary outcome was the occurrence of major cardiovascular events within thirty days. RESULTS: During the study period, 1,149 patients were evaluated with STEMI, and 331 patients underwent thrombi aspiration, leaving 199 patients available for analysis. It was identified recent thrombi in 116 patients (58%) and old thrombi in 83 patients (42%). Recent thrombi have greater infiltration of red blood cells than old thrombi (p = 0.02), but there were no statistically significant differences between other clinical, angiographic, laboratory, and histopathological features and medications in both group of patients. The rates of clinical outcomes were similar in both groups. CONCLUSIONS: Recent thrombi were identified in 58% of patients with STEMI and it was observed an association with infiltration of red blood cells. There was no association between histopathological features of thrombi and clinical variables and cardiovascular outcomes.


Subject(s)
Coronary Thrombosis/pathology , Myocardial Infarction/therapy , Aged , Female , Humans , Male , Middle Aged , Myocardial Infarction/surgery , Percutaneous Coronary Intervention , Prospective Studies , Stents , Thrombectomy
11.
Arq. bras. cardiol ; 111(4): 587-593, Oct. 2018. tab, graf
Article in English | LILACS | ID: biblio-973765

ABSTRACT

Abstract Background: In patients with acute ST-segment elevation myocardial infarction (STEMI), the time elapsed from symptom onset to receiving medical care is one of the main mortality predictors. Objective: To identify independent predictors of late presentation in patients STEMI representative of daily clinical practice. Methods: All patients admitted with a diagnosis of STEMI in a reference center between December 2009 and November 2014 were evaluated and prospectively followed during hospitalization and for 30 days after discharge. Late presentation was defined as a time interval > 6 hours from chest pain onset until hospital arrival. Multiple logistic regression analysis was used to identify independent predictors of late presentation. Values of p < 0.05 were considered statistically significant. Results: A total of 1,297 patients were included, with a mean age of 60.7 ± 11.6 years, of which 71% were males, 85% Caucasians, 72% had a mean income lower than five minimum wages and 66% had systemic arterial hypertension. The median time of clinical presentation was 3.00 [1.40-5.48] hours, and approximately one-quarter of the patients had a late presentation, with their mortality being significantly higher. The independent predictors of late presentation were Black ethnicity, low income and diabetes mellitus, and a history of previous heart disease was a protective factor. Conclusion: Black ethnicity, low income and diabetes mellitus are independent predictors of late presentation in STEMI. The identification of subgroups of patients prone to late presentation may help to stimulate prevention policies for these high-risk individuals.


Resumo Fundamento: Em pacientes com infarto agudo do miocárdio com supradesnivelamento do segmento ST (IAMCSST), o tempo decorrido desde o início dos sintomas até a busca por atendimento médico é um dos principais preditores de mortalidade. Objetivo: Identificar preditores independentes de apresentação tardia em pacientes com IAMCSST representativos da prática clínica diária. Métodos: Todos os pacientes admitidos com diagnóstico de IAMCSST em um centro de referência, no período de dezembro de 2009 a novembro de 2014, foram avaliados e prospectivamente acompanhados, durante a hospitalização e por 30 dias após a alta. A apresentação tardia foi definida como tempo maior que 6 horas desde o início da dor torácica até a chegada ao hospital. Análise de regressão logística múltipla foi usada para identificar os preditores independentes de apresentação tardia. Foi considerado estatisticamente significativo p < 0,05. Resultados: Foram incluídos 1.297 pacientes, com idade média de 60,7 ± 11,6 anos, 71% do sexo masculino, 85% da raça branca, 72% com renda média menor que cinco salários mínimos e 66% com hipertensão arterial sistêmica. A mediana do tempo de apresentação clínica foi de 3,00 [1,40-5,48] horas, sendo que aproximadamente um quarto dos pacientes apresentou-se tardiamente, e a mortalidade deles foi significativamente maior. Os preditores independentes de apresentação tardia foram raça negra, baixa renda e diabetes melito, e história de doença cardíaca prévia foi fator protetor. Conclusão: Raça negra, baixa renda e diabetes melito são preditores independentes de apresentação tardia no IAMCSST. A identificação de subgrupos de pacientes propensos à apresentação tardia pode auxiliar a estimular políticas de prevenção nestes indivíduos de alto risco.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , ST Elevation Myocardial Infarction/physiopathology , Socioeconomic Factors , Time Factors , Brazil , Logistic Models , Multivariate Analysis , Prospective Studies , Risk Factors , Statistics, Nonparametric , Diabetes Mellitus/physiopathology , ST Elevation Myocardial Infarction/mortality
12.
Arq. bras. cardiol ; 111(3): 410-416, Sept. 2018. tab, graf
Article in English | LILACS | ID: biblio-973759

ABSTRACT

Abstract Background: Anger control was significantly lower in patients with coronary artery disease (CAD), regardless of traditionally known risk factors, occurrence of prior events or other anger aspects in a previous study of our research group. Objective: To assess the association between anger and CAD, its clinical course and predictors of low anger control in women submitted to coronary angiography. Methods: This is a cohort prospective study. Anger was assessed by use of Spielberger's State-Trait Anger Expression Inventory (STAXI). Women were consecutively scheduled to undergo coronary angiography, considering CAD definition as ≥ 50% stenosis of one epicardial coronary artery. Results: During the study, 255 women were included, being divided into two groups according to their anger control average (26.99). Those with anger control below average were younger and had a family history of CAD. Patients were followed up for 48 months to verify the occurrence of major cardiovascular events. Conclusion: Women with CAD undergoing coronary angiography had lower anger control, which was associated with age and CAD family history. On clinical follow-up, event-free survival did not significantly differ between patients with anger control above or below average.


Resumo Fundamento: O controle da raiva mostrou-se significativamente mais baixo em pacientes com doença arterial coronariana (DAC), independentemente dos fatores de risco tradicionais conhecidos, da ocorrência de eventos prévios, ou de outros aspectos da raiva em estudo prévio do nosso grupo. Objetivo: Avaliar a associação entre raiva e DAC, sua evolução clínica e preditores de baixo controle de raiva em mulheres submetidas a coronariografia. Métodos: Trata-se de estudo de coorte prospectivo. Avaliou-se raiva com o Inventário de Expressão de Raiva como Estado e Traço de Spielberger (STAXI). Todas as mulheres agendadas para realização de angiografia coronariana durante o período de estudo foram abordadas consecutivamente. Definiu-se DAC como estenose de uma artéria coronária epicárdica ≥ 50%. Resultados: Este estudo incluiu 255 mulheres, que foram divididas em dois grupos, acima e abaixo da média do controle de raiva (26,99). Aquelas com controle abaixo da média eram mais jovens e tinham história familiar de DAC. As pacientes foram seguidas por 48 meses para verificar a ocorrência de eventos cardiovasculares maiores. Conclusão: As mulheres com DAC submetidas a coronariografia apresentaram menor controle de raiva, que se associou com idade e história familiar de DAC. No seguimento clínico, a sobrevida livre de evento não diferiu significativamente entre pacientes com controle de raiva acima da média e aquelas com controle abaixo.


Subject(s)
Humans , Female , Middle Aged , Aged , Coronary Artery Disease/psychology , Anger , Personality Inventory , Coronary Artery Disease/mortality , Coronary Artery Disease/diagnostic imaging , Logistic Models , Prospective Studies , Risk Factors , Follow-Up Studies , Coronary Angiography/methods , Statistics, Nonparametric , Diabetes Mellitus/psychology , Kaplan-Meier Estimate
13.
Arq Bras Cardiol ; 98(2): 151-60, 2012 Feb.
Article in English, Portuguese | MEDLINE | ID: mdl-22286326

ABSTRACT

BACKGROUND: Hypertension is one of the major cardiovascular risk factors affecting more than one billion people. The low awareness of the disease is one of the greatest difficulties related to hypertension. The population screening for hypertension is widely recognized as an effective strategy to detect new cases, but until now, there is no instrument that has become feasible for mass screening of the population. OBJECTIVE: Evaluate the accuracy and reproducibility of the Rastreometer, a new instrument for the screening of hypertension for community health agents. METHODS: Cross-sectional study with a sample of 436 individuals served by the Family Health Strategy. The evaluation was conducted comparing the results of blood pressure obtained by the oscillometric method and reading of the Rastreometer performed by community health agents. RESULTS: The Rastreometer presented a sensitivity of 81.3% and a specificity of 85.6% when assessed in relation to the values of systolic pressure. The operators' performance influenced the results of the Rastreometer independently (p = 0.0001). The Rastreometer showed substantial reproducibility (Kendall’s W 0.71). CONCLUSION: The Rastreometer, when operated by community health agents, showed good sensitivity, specificity and reproducibility, especially when evaluated with the values of systolic pressure, tending to confirm this new instrument as a method of screening for hypertension in primary health care.


Subject(s)
Blood Pressure Determination/instrumentation , Blood Pressure/physiology , Hypertension/diagnosis , Oscillometry/methods , Sphygmomanometers , Blood Pressure Determination/methods , Community Health Workers , Epidemiologic Methods , Female , Humans , Male , Middle Aged , Sphygmomanometers/adverse effects , Sphygmomanometers/classification
14.
Int. j. cardiovasc. sci. (Impr.) ; 29(4): f:253-l:261, jul.-ago. 2016. tab, graf
Article in Portuguese | LILACS | ID: biblio-831819

ABSTRACT

Fundamentos: As recomendações das diretrizes para o tratamento de pacientes com infarto agudo do miocárdio com supradesnivelamento do segmento ST (IAMCSST) são baseados principalmente em dados de estudos clínicos randomizados. Objetivos: Procuramos avaliar as tendências temporais das características, do tratamento e da evolução de pacientes com IAMCSST que representassem a prática clínica diária. Métodos: Estudo de coorte prospectivo incluindo todos os pacientes com IAMCSST que procuraram nosso serviço no período de 2010 a 2013. Foram avaliados os aspectos clínicos, angiográficos, laboratoriais e de tratamento, além dos eventos cardiovasculares maiores (ECVM) em 30 dias. Resultados: O escore de risco TIMI médio e a maioria das características clínicas e angiográficas iniciais dos 1973 pacientes incluídos se mantiveram estáveis de 2010 a 2013, com exceção de diabetes mellitus (cuja frequência aumentou de 21% para 28%; p < 0,01). Foi realizada ICP primária em 95% dos casos, e o tempo porta-balão diminuiu de 1,27 para 1,11 horas (p < 0,01). Em relação ao tratamento, houve aumento significativo do uso de clopidrogrel 600mg em bolus (de 75% em 2010 para 93% em 2013; p < 0,001), no uso de anticoagulação pré-cateterização (50% versus 91%; p<0,001), e de acesso radial na ICPp (9% versus 66%; p < 0,001); houve, ainda, um menor uso de beta-bloqueadores (72% versus 63%; p < 0,001). Houve redução de ECVM de 17,4% para 9,5% (p < 0,05). Foram fatores preditivos independentes de ECVM as características iniciais, o acesso radial, o uso de beta-bloqueadores e de anticoagulação pré-cateterização. Conclusões: As características iniciais de pacientes com IAMCSST mantiveram-se estáveis durante um período de quatro anos, com exceção de diabetes mellitus, cuja frequência aumentou significativamente. Houve mudanças significativas no tratamento clínico e intervencionista e diminuição significativa nos desfechos cardiovasculares adversos em curto prazo. Os preditores de melhor evolução foram as características iniciais, uso de betabloqueadores, de anticoagulação pré-cateterização e acesso radial


Background: Guideline recommendations for the management of patients with ST-elevation myocardial infarction (STEMI) are mainly based on data from randomized clinical trials. Objectives: We sought to assess temporal trends in characteristics, treatment and outcomes of patients with STEMI representative of the daily practice. Methods: Prospective cohort study including all patients with STEMI who presented at our institution from 2010 to 2013. Clinical, angiographic, laboratory, treatment aspects and 30-day major cardiovascular events (MACEs) were assessed and compared over the years. Results: The mean TIMI risk score, and most baseline clinical and angiographic characteristics of the 1973 patients included remained stable from 2010 to 2013, except for diabetes mellitus (whose frequency increased from 21% to 28%; p < 0.01). Primary PCI was performed in 95% of cases, and the door-to-balloon time decreased from 1.27 to 1.11 hours (p < 0.01). Regarding treatment, there were significant increases in the use of 600 mg boluses of clopidogrel (75% in 2010 vs 93% in 2013; p < 0.001), upstream anticoagulant (50% vs 91%; p < 0.001) and the radial approach in pPCI (9% vs 66%; p < 0.001), and lower use of beta-blockers (72% vs 63%; p < 0.001). MACE decreased from 17.4% to 9.5% (p < 0.05). Independent predictors of MACE were baseline characteristics, the radial approach, and use of beta-blockers and upstream anticoagulant. Conclusions: The baseline characteristics of patients with STEMI remained stable over a four-year period, except for the incidence of diabetes mellitus, which increased significantly. Medical and interventional treatments significantly changed, and short-term adverse cardiovascular outcomes significantly decreased. Predictors of better outcomes were baseline characteristics, use of beta-blockers and upstream anticoagulant, and the radial approach


Subject(s)
Humans , Male , Female , Aged , Clinical Studies as Topic/methods , Delivery of Health Care/methods , Evidence-Based Practice/methods , Myocardial Infarction/mortality , Myocardial Infarction/therapy , Treatment Outcome , Analysis of Variance , Cardiovascular Diseases/physiopathology , Cohort Studies , Heparin/administration & dosage , Multivariate Analysis , Percutaneous Coronary Intervention/methods , Predictive Value of Tests , Risk Factors
15.
Rev. bras. cardiol. invasiva ; 23(2): 119-123, abr.-jun. 2015. tab, graf
Article in Portuguese | LILACS | ID: lil-786994

ABSTRACT

Introdução: Na prática clínica, os tipos 1 (trombose coronariana) e 2 (desequilíbrio entre a demanda e ofertade oxigênio) de infarto agudo do miocárdio (IAM) não são claramente distinguidos. O objetivo deste estudo foi avaliar a prevalência e a etiologia do IAM tipo 2, e comparar seu perfil com o do tipo 1. Métodos: Foram analisados pacientes admitidos com IAM com supradesnivelamento do segmento ST(IAMCST) com < 12 horas, encaminhados para coronariografia, no período de 2009 a 2013. Resultados: Foram incluídos 1.960 pacientes, sendo 1.817 analisados, dos quais 1.786 (98,3%) com IAM tipo 1 e 31 (1,7%) do tipo de 2. Todos os pacientes com IAM tipo 2 apresentaram coronárias sem lesões significativas e, em 36% dos casos, discinesia apical. Os pacientes com IAM tipo 2 apresentaram, em geral, perfil clínico e laboratorial semelhante aos do tipo 1, com exceção da idade mais jovem, menores níveis de marcadores de necrose miocárdica, maior probabilidade de apresentarem fluxo TIMI 3 pré e maior fração de ejeção do ventrículo esquerdo. Aos 30 dias, a mortalidade (3,2 vs. 9,0%; p = 0,23) e a ocorrência de morte, reinfarto ou necessidade de revascularização do vaso-alvo (3,2 vs. 13,0%; p = 0,09) foram numericamente menores no IAM tipo 2. Conclusões: Uma pequena fração de pacientes com IAMCST foi classificada como de tipo 2; exibiram anormalidades estruturais isoladas ou associadas à ausência de lesões significativas; mostraram poucas diferenças no perfil clínico e laboratorial, e desfechos clínicos semelhantes aos 30 dias, comparados aos pacientes com IAM tipo 1.


Background: In clinical practice, type-1 (coronary thrombosis) and type-2 (imbalance between oxygen demand and supply) acute myocardial infarction (AMI) are not clearly differentiated. The aim of this study was to evaluate the prevalence and etiology of type-2 AMI and compare its profile with that of type-1 AMI. Methods: Patients admitted with ST-segment elevation AMI (STEMI) < 12 hours of symptom onset, and referred for coronary angiography, from 2009 to 2013, were analyzed. Results: There were 1,960 patients included; 1,817 were analyzed, of whom 1,786 (98.3%) had type-1 AMI, and 31 (1.7%), type-2. All patients with type-2 AMI showed no significant coronary lesions, and 36% of the cases had apical dyskinesia. Type-2 AMI patients had, in general, a clinical and laboratory profile that was similar to those with type-1, except for the younger age, lower levels of myocardial necrosis markers, higher probability of having pre-TIMI 3 flow and higher left ventricular ejection fraction. At 30 days, mortality (3.2vs. 9.0%; p = 0.23) and the occurrence of death, reinfarction, or need for target-vessel revascularization (3.2vs. 13.0%; p = 0.09) were numerically lower in type-2 AMI. Conclusions: Few patients with STEMI were classified as type-2; they had structural abnormalities, isolatedor associated with the absence of significant lesions; showed little difference regarding the clinical and laboratory profile, and similar clinical outcomes at 30 days, when compared to patients with type-1 AMI.


Subject(s)
Humans , Male , Female , Middle Aged , Myocardial Infarction/etiology , Myocardial Infarction/mortality , Patients , Health Profile , Prevalence , Coronary Angiography/methods , Analysis of Variance , Aspirin/administration & dosage , Tertiary Healthcare/methods , Brazil/epidemiology , Prospective Studies , Risk Factors , Heparin/administration & dosage
16.
Arq. bras. cardiol ; 105(6): 573-579, Dec. 2015. tab
Article in Portuguese | LILACS | ID: lil-769533

ABSTRACT

Abstract Background: Due to the importance of coronary artery disease (CAD), continuous investigation of the risk factors (RFs) is needed. Objective: To evaluate the prevalence of RFs for CAD in cities in Rio Grande do Sul State, and compare it with that reported in a similar study conducted in the same cities in 2002. Methods: Cross-sectional study on 1,056 healthy adults, investigating the prevalence and absolute and relative frequencies of the following RFs for CAD: obesity, systemic arterial hypertension (SAH), dyslipidemias, smoking, sedentary lifestyle, diabetes mellitus, and family history, as well as age and sex. Data was collected in 19 cities, host of the Offices of the Regional Coordinators of Health, as in the 2002 study. Results: Twenty-six percent of the sample consisted of older adults and 57% were women. The prevalence of sedentary lifestyle was 44%, history family 50%, smoking 23%, overweight/obesity 68%, dyslipidemia (high cholesterol levels) 43%, SAH 40%, and diabetes 11%. When compared to the 2002 study, the prevalence of active smoking and sedentary behavior decreased, whereas the prevalence of hypertension, dyslipidemia and obesity increased. Obesity is the most prevalent RF in women, and SAH the most prevalent in men. Conclusions: The prevalence of RFs for CAD in Rio Grande do Sul State remains high. Hypertension, obesity and dyslipidemia are still prevalent and require major prevention programs. Smoking and physical inactivity have decreased in the state, suggesting the efficacy of related campaigns.


Resumo Fundamento: Diante da importância da doença arterial coronariana (DAC), é necessário pesquisar continuamente seus fatores de risco (FR). Objetivo: Conhecer a prevalência dos FR da DAC em cidades do Estado do Rio Grande do Sul (RS), e compará-la com a encontrada em pesquisa semelhante realizada nas mesmas cidades em 2002. Métodos: Estudo transversal de uma amostra de 1056 indivíduos adultos, em que se pesquisou a prevalência e frequências absolutas e relativas dos seguintes FR para a DAC: obesidade, hipertensão arterial sistêmica (HAS), dislipidemias, tabagismo, sedentarismo, diabetes mellitus, e antecedentes familiares de cardiopatia isquêmica, além de idade e gênero. A coleta de dados foi realizada em 19 cidades sede das Coordenadorias Regionais de Saúde do RS, como feito em 2002. Resultados: A amostra foi constituída de 26% de idosos e 57% de mulheres. As prevalências dos FR foram de 44% de sedentarismo, 50% de antecedentes familiares, 23% de tabagismo, 68% de sobrepeso/obesidade, 43% de dislipidemia (colesterol elevado), 40% de HAS, e 11% de diabetes. Quando comparado ao estudo de 2002, verificou-se que a população de fumantes ativos e sedentários diminuiu, e a de hipertensos, dislipidêmicos e obesos aumentou. A obesidade é o FR mais prevalente em mulheres, e a HAS o mais prevalente em homens. Conclusão: A prevalência dos FR da DAC no RS continua alta. Fatores como hipertensão, obesidade, dislipidemia continuam elevados e demandam maiores programas de prevenção. O hábito de fumar e a inatividade física têm diminuído no estado, sugerindo a eficácia das campanhas relacionadas.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Coronary Artery Disease/etiology , Diabetes Mellitus/epidemiology , Dyslipidemias/epidemiology , Hypertension/epidemiology , Obesity/epidemiology , Smoking/epidemiology , Age Factors , Brazil/epidemiology , Cross-Sectional Studies , Coronary Artery Disease/epidemiology , Diabetes Complications , Dyslipidemias/complications , Hypertension/complications , Obesity/complications , Prevalence , Risk Factors , Sedentary Behavior , Sex Factors , Smoking/adverse effects
17.
Rev. bras. cardiol. invasiva ; 23(1): 48-51, abr.-jun.2015. tab
Article in Portuguese | LILACS | ID: lil-782176

ABSTRACT

A epidemiologia do infarto agudo do miocárdio com supradesnivelamento do segmento ST(IAMCST) tem se modificado nos últimos anos, com incidência maior em jovens. Nosso objetivo foi comparar o perfil clínico, laboratorial e angiográfico, e os desfechos clínicos em 30 dias de pacientes ≤ 40 anos àqueles > 40 anos submetidos à intervenção coronária percutânea primária (ICPp).Métodos: Estudo de coorte prospectivo com pacientes consecutivos submetidos à ICPp entre 2009 e 2011. Resultados: No período, 1.055 pacientes foram incluídos, sendo identificados 3,3% com ≤ 40 anos. Pacientes jovens eram mais frequentemente negros, tabagistas e com história familiar de doença coronária, e menos frequentemente hipertensos e dislipidêmicos. Nos pacientes ≤ 40 anos, a dosagem de leucócitos e da troponina ultrassensível na admissão foi maior, e a lipoproteína de alta densidade-colesterol, menor.A artéria descendente anterior como vaso culpado e a fração de ejeção do ventrículo esquerdo não foramdiferentes entre os grupos. Apesar de o fluxo TIMI 3 pré ser similar, os jovens mostraram maior prevalênciade blush miocárdico 3 pré-procedimento. O tempo porta-balão foi menor nos pacientes mais jovens (1,0 hora [0,8-1,4 hora] vs. 1,3 hora [0,9-1,7 hora]; p = 0,03). Em 30 dias, os pacientes ≤ 40 anos apresentaram mortalidade de 0% vs. 8,8% nos pacientes > 40 anos (p = 0,07). Conclusões: Pacientes ≤ 40 anos com IAMCST e submetidos à ICPp apresentam diferenças nos perfis clínico,angiográfico e do procedimento quando comparados àqueles > 40 anos. Nesta análise, representativa da prática médica atual, a mortalidade em 30 dias desses pacientes foi muito baixa...


The epidemiology of acute myocardial infarction with ST-segment elevation (STEMI) has been modified in recent years, focusing on young people. Our goal was compare the clinical profile, laboratory, angiographic, and 30-day clinical outcomes of patients ≤ 40 years with those > 40 years undergoingprimary percutaneous coronary intervention (pPCI). Methods: Prospective cohort study of consecutive patients undergoing pPCI between 2009 and 2011. Results: A total of 1,055 patients were included, 3.3% of them ≤ 40 years. Young patients were more often black, smokers and with a family history of coronary artery disease, and less often hypertensive and dyslipidemic.In patients ≤ 40 years, leukocyte count and ultrasensitive troponin levels at admission were higher, and high density lipoprotein-cholesterol, lower. The left anterior descending artery as a culprit vessel and left ventricular ejection fraction did not differ between groups. Although the TIMI 3 flow pre-intervention was similar, young people showed higher prevalence of myocardial blush 3 pre-procedure. The door-to-balloon time was lower in younger patients (1.0 hour [0.8-1.4 hour] vs. 1.3 hour [0.9-1.7 hour]; p = 0.03). At 30 days, patients ≤ 40 years had a mortality of 0% vs. 8.8% for patients > 40 years (p = 0.07). Conclusions: Patients ≤ 40 years with STEMI and undergoing pPCI show differences in clinical, angiographic and procedural characteristics compared to those > 40 years. In this analysis, representative of the current medical practice, the 30-day mortality of these patients was very low...


Subject(s)
Humans , Male , Female , Adult , Adolescent , Percutaneous Coronary Intervention/methods , Patients , Health Profile , Data Interpretation, Statistical , Cardiovascular Diseases/physiopathology , Prospective Studies , Risk Factors , Myocardial Infarction/physiopathology , Treatment Outcome
18.
Rev. bras. cardiol. invasiva ; 23(3): 190-194, jul.-set.2015. tab
Article in Portuguese | LILACS | ID: lil-794196

ABSTRACT

Em nosso, país estima-se que aproximadamente 27% das mulheres em idade fértil utilizemanticoncepcional oral (ACO). A apresentação e a evolução clínica do infarto agudo do miocárdio (IAM) nessasmulheres ainda não foi descrita em nosso meio. O objetivo do presente estudo foi analisar o perfil clínico, ascaracterísticas angiográficas, os aspectos técnicos do procedimento e os desfechos de usuárias de ACO quetiveram IAM e foram encaminhadas à intervenção coronariana percutânea (ICP) primária. Métodos: Mulheres < 55 anos que apresentaram IAM com supradesnivelamento do segmento ST e foram encaminhadas à ICP primária foram sequencialmente incluídas e categorizadas em dois grupos: com e sem uso atual de ACO. Resultados: Incluímos 257 pacientes, sendo que 19 (7,4%) usavam ACO. Estas eram mais jovens (42,3 ± 6,2 anos vs. 48,4 ± 5,7 anos; p < 0,001), com menos fatores de risco tradicionais para doença arterial coronariana, mas apresentavam proteína C-reativa e fibrinogênio séricos mais elevados. O delta T foi semelhante (4,00 [1,25 a 6,86] horas vs. 4,50 [2,50 a 7,64] horas; p = 0,54), mas o tempo porta-balão foi maior nas pacientes em uso de ACO (1,41 [0,58 a 1,73] hora vs. 1,16 [0,91 a 1,51] hora; p = 0,02). Estas pacientes foram mais frequentemente submetidas à tromboaspiração (52,6% vs. 25,6%; p = 0,04). Após o evento índice, elas não apresentaram desfechosaterotrombóticos em até 2 anos de acompanhamento (0 vs. 15,2%; p = 0,08). Conclusões: Neste estudo, encontramos perfil clínico e desfechos diferentes entre mulheres em idadereprodutiva, usuárias ou não de ACO, e submetidas à ICP primária. Estudos com maior número de pacientes sãonecessários para confirmar tais resultados...


In Brazil, it is estimated that approximately 27% of women of childbearing age use oral contraceptives (OC). The presentation and clinical course of acute myocardial infarction (AMI) in these women has yet to be described in Brazil. The aim of this study was to analyze the clinical profile, angiographic characteristics, technical aspects of the procedure, and the outcomes in women using OC who had an AMI and were submitted to primary percutaneous coronary intervention (PCI). Methods: Women aged < 55 years who had acute ST segment elevation myocardial infarct and were referred to primary PCI were sequentially included and categorized into two groups: with and without current use of OC. Results: We have included 257 patients, of whom 19 (7.4%) used OC. These patients were younger (42.3 ± 6.2 years vs. 48.4 ± 5.7 years; p < 0.001), with fewer traditional risk factors for coronary artery disease, but had higher serum levels of C-reactive protein and fibrinogen. The delta T was similar (4.00 [1.25 to 6.86] hours vs.4.50 [2.50 to 7.64] hours; p = 0.54), but the door-to-balloon time was longer in patients taking OC (1.41 [0.58 to 1.73] hour vs. 1.16 [0.91 to 1.51] hour, p = 0.02). These patients were more frequently submitted to thrombus aspiration (52.6% vs. 25.6%; p = 0.04). After the index event, they had no atherothrombotic outcomes in up to 2years of follow-up (0 vs. 15.2%; p = 0.08). Conclusions: In this study, different clinical profiles and outcomes were found among women of reproductive age, users or non-users of OC, and submitted to primary PCI. Studies with a larger number of patients are required to confirm these results...


Subject(s)
Humans , Female , Middle Aged , Contraceptive Agents , Contraceptive Agents/adverse effects , Myocardial Infarction/physiopathology , Percutaneous Coronary Intervention/methods , Women , Health Profile , Angiography/methods , Data Interpretation, Statistical , Risk Factors , Hemorrhage/complications , C-Reactive Protein/analysis , Stents , Thrombosis/complications
19.
Rev. bras. cardiol. invasiva ; 23(2): 102-107, abr.-jun. 2015. tab, graf
Article in Portuguese | LILACS | ID: lil-786991

ABSTRACT

Introdução: Historicamente, pacientes com cirurgia de revascularização do miocárdio (CRM) prévia submetidos à intervenção coronária percutânea (ICP) primária têm pior prognóstico que pacientes semCRM prévia. No entanto, análises mais contemporâneas contestam esses achados. Nosso objetivo foi avaliar os desfechos clínicos de 30 dias em pacientes com e sem CRM prévia submetidos à ICP primária. Métodos: Estudo de coorte prospectivo extraído do banco de dados do Instituto de Cardiologia do RioGrande do Sul, contendo 1.854 pacientes submetidos à ICP primária. Resultados: Pacientes com CRM prévia (3,8%) mostraram perfil clínico, em geral, mais grave. O tempo deinício dos sintomas até a chegada ao hospital foi menor nesse grupo (2,50 horas [1,46-3,66] vs. 3,99 horas[1,99-6,50]; p < 0,001) e o tempo porta-balão foi semelhante (1,33 hora [0,85-2,07] vs. 1,16 hora [0,88-1,58];p = 0,12). O acesso femoral foi mais usado no grupo com CRM prévia (91,5% vs. 62,5%; p < 0,001). O uso de tromboaspiração manual foi menor nesse grupo (16,9% vs. 31,1%; p = 0,007), mas não houve diferença no uso de inibidor da glicoproteína IIb/IIIa (28,2% vs. 32,4%; p = 0,28). O sucesso angiográfico foi menor no grupo com CRM prévia (80,3% vs. 93,3%; p = 0,009). Aos 30 dias, pacientes com CRM prévia apresentaram taxas similares de eventos cardíacos adversos maiores (14,1% vs. 11,2%; p = 0,28), e a mortalidade, embora numericamente mais alta, não foi estatisticamente significativa (13,2% vs. 7,0%; p = 0,07).Conclusões: Nessa análise contemporânea, pacientes com CRM prévia submetidos à ICP primária apresentaram perfil clínico mais grave e menor sucesso angiográfico, porém não mostraram diferenças nos desfechos clínicos em 30 dias.


Background: Historically, patients with prior coronary artery bypass graft (CABG) surgery undergoing primary percutaneous coronary intervention (PCI) have a worse prognosis than patients without prior CABG. However, more contemporary analyses have contested these findings. This study’s aim was to evaluate the 30-day clinical outcomes in patients with and without prior CABG submitted to primary PCI. Methods: Prospective cohort study, extracted from the database of Instituto de Cardiologia do Rio Grandedo Sul, containing 1,854 patients undergoing primary PCI. Results: Patients with prior CABG (3.8%) showed, in general, a more severe clinical profile. The time of symptom onset until arrival at the hospital was shorter in this group (2.50 hours [1.46 to 3.66] vs. 3.99 hour [1.99 to 6.50]; p < 0.001), while the door-to-balloon time was similar (1.33 hour [0.85 to 2.07] vs.1.16 hour [0.88 to 1.58]; p = 0.12). Femoral access was more often used in the group with prior CABG(91.5% vs. 62.5%; p < 0.001). Manual thrombus aspiration was less often performed in this group (16.9% vs. 31.1%; p = 0.007), but there was no difference regarding the use of glycoprotein IIb/IIIa inhibitors (28.2% vs. 32.4%, p = 0.28). Angiographic success was lower in the group with prior CABG (80.3% vs. 93.3%; p = 0.009). At 30 days, patients with prior CABG had similar rates of major adverse cardiac events (14.1%vs. 11.2%; p = 0.28), and mortality, although numerically higher, was not statistically significant (13.2%vs. 7.0%, p = 0.07). Conclusions: In this contemporary analysis, patients with prior CABG undergoing primary PCI had amore severe clinical profile and lower angiographic success, but showed no differences regarding 30-day clinical outcomes.


Subject(s)
Humans , Male , Female , Middle Aged , Tertiary Healthcare/methods , Myocardial Infarction/complications , Myocardial Infarction/therapy , Percutaneous Coronary Intervention/methods , Patients , Myocardial Revascularization/mortality , Angiography/methods , Analysis of Variance , Thoracic Surgery/methods , Cohort Studies , Risk Factors , Platelet Aggregation Inhibitors/administration & dosage , Stents
SELECTION OF CITATIONS
SEARCH DETAIL